Mitesco (MITI) Amortization - Deferred Charges (2023)
Mitesco (MITI) reported Amortization - Deferred Charges of $1.2 million for Q3 2023, down 81.1% on a QoQ basis from $6.4 million in Q2 2023.
Mitesco (MITI) has 1 years of Amortization - Deferred Charges data on file, last reported at $1.2 million in Q3 2023.
- Quarterly Amortization - Deferred Charges changed N/A year-over-year to $1.2 million in Q3 2023, while the trailing twelve-month figure through Sep 2024 was $1.2 million (down 84.11% YoY) and the FY2023 annual result came in at $7.6 million, changed N/A from the prior year.
- Amortization - Deferred Charges fell to $1.2 million in Q3 2023 per MITI's latest filing, from $6.4 million in the prior quarter.
- Across five years, Amortization - Deferred Charges topped out at $6.4 million in Q2 2023 and bottomed at $1.2 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Mitesco | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 6.43 Mn |
| Jun 30, 2023 | 6.43 Mn |